BioSpace News Archive

Biotech Beach

NuVasive to Sponsor and Participate at Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum ’22

NuVasive, Inc. today announced it will continue its partnership with the Society for Minimally Invasive Spine Surgery (SMISS) as a sponsor and will attend the SMISS Annual Forum ’22 held September 29 to October 1, 2022 in Las Vegas.

September 26, 2022
·
3 min read
Deals

Anebulo Pharmaceuticals Announces $6.6 Million Private Placement Financing

Anebulo Pharmaceuticals, Inc. today announced that it has agreed to sell an aggregate of 2,264,650 common shares and accompanying warrants to purchase up to 2,264,650 shares of common stock.

September 26, 2022
·
3 min read
Drug Development

Anebulo Pharmaceuticals Announces Positive Interim Data for ANEB-001 from Part B of its Phase 2 Clinical Trial for Acute Cannabinoid Intoxication

Anebulo Pharmaceuticals, Inc. today announced positive interim data from the first two cohorts of Part B of its ongoing Phase 2 clinical trial evaluating ANEB-001 as a treatment for ACI.

September 26, 2022
·
8 min read
DAMONA Pharmaceuticals Raises US$5.5 Million Seed Stage Financing to Advance Lead Molecule Development to Treat Cognitive Deficits Associated with Depression and Diseases of Aging

DAMONA Pharmaceuticals today announced the closing of a seed stage financing round to support the development of its lead therapeutic for the treatment of cognitive symptoms associated with depression and diseases of aging.

September 26, 2022
·
5 min read
Genetown

Relay Therapeutics to Participate in Fireside Chat at Bank of America Securities 2022 Precision Oncology Conference

Relay Therapeutics, Inc. is scheduled to participate in a virtual fireside chat at the Bank of America Securities 2022 Precision Oncology Conference on Monday, October 3, 2022, at 2:50 p.m. ET.

September 26, 2022
·
1 min read
Theratechnologies to Announce Third Quarter 2022 Financial Results and Provide Business Update

Theratechnologies Inc. today announced that it will report financial results for its third quarter of fiscal 2022 ended August 31, on Thursday, October 13, 2022.

September 26, 2022
·
1 min read
Genetown

Intellia Therapeutics to Present at October Healthcare Investor Conferences

Intellia Therapeutics, Inc. today announced that members of its management team will be presenting at the following upcoming investor conferences in October.

September 26, 2022
·
1 min read
Deals

Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment from Petrichor

Fennec Pharmaceuticals Inc. today announced that it has completed the second closing of $20 million of senior secured promissory notes under our previously announced investment agreement with Petrichor Healthcare Capital Management.

September 26, 2022
·
9 min read
BioMidwest

Karmanos Cancer Institute first to receive innovative, FDA-approved SoftVue™ Breast Imaging System

The Barbara Ann Karmanos Cancer Institute, the world-renowned, Detroit-based National Cancer Institute-Designated Comprehensive Cancer Center, is the first to receive the SoftVue™ 3D Whole Breast Ultrasound Tomography System (SoftVue™), following its approval by the Food and Drug Administration.

September 26, 2022
·
4 min read
Drug Development

MoonLake Immunotherapeutics to initiate global Phase 2 study of the Nanobody® sonelokimab in patients with active psoriatic arthritis

MoonLake Immunotherapeutics to initiate global Phase 2 study of the Nanobody® sonelokimab in patients with active psoriatic arthritis.

September 26, 2022
·
9 min read